GastroMycin with Bismuth Salts
On sale on the US market (according to the DSLD)
Allergy Research Group, food supplement from the US market
GastroMycin with Bismuth Salts (Allergy Research Group), a food supplement au code-barres 713947710306, is described by its US market label. If sold in France, it would be subject to 1 point of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
- Conditions légales
Aloe vera (L.) Burm. f.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes et une mention déconseillant l'usage prolongé
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Allergy Research Group
- Barcode
- 713947710306
- Form
- Capsule
- One serving
- 4 capsules
- Servings
- up to 4 servings per day
- Other ingredients (in English, as written)
- Hydroxypropyl Methylcellulose, L-Leucine
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Bismuth | Other | 240 mg |
| Activated Charcoal | Other substance | 200 mg |
| Oregon Grape powder | Plant | 400 mg |
| Neem extract (Azadirachta indica) | Plant | 300 mg |
| Licorice extract | Plant | 200 mg |
| Aloe vera extract (Aloe vera) | Plant | 40 mg |
| Cinnamon extract | Plant | 20 mg |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: GastroMycin with Bismuth Salts
Entered into DSLD on 18 December 2021. On sale on the US market (according to the DSLD).- Same quantity, different name: Oregon Grape (root) powder in this version; Oregon Grape powder on the displayed label (400 mg)
Official label: GastroMycin with Bismuth Salts
Entered into DSLD on 23 August 2020. Withdrawn from the US market on 2 August 2021 (according to the DSLD).- Same quantity, different name: Cinnamon (bark) extract in this version; Cinnamon extract on the displayed label (20 mg)
- Same quantity, different name: Licorice (root) extract in this version; Licorice extract on the displayed label (200 mg)
- Same quantity, different name: Neem (leaf) extract in this version; Neem extract on the displayed label (300 mg)
- Same quantity, different name: Oregon Grape (root) powder in this version; Oregon Grape powder on the displayed label (400 mg)
Official label: GastroMycin with Bismuth Salts
Entered into DSLD on 23 August 2020. Withdrawn from the US market on 2 August 2021 (according to the DSLD).- Same quantity, different name: Cinnamon (bark) extract in this version; Cinnamon extract on the displayed label (20 mg)
- Same quantity, different name: Licorice (root) extract in this version; Licorice extract on the displayed label (200 mg)
- Same quantity, different name: Neem (leaf) extract in this version; Neem extract on the displayed label (300 mg)
- Same quantity, different name: Oregon Grape (root) powder in this version; Oregon Grape powder on the displayed label (400 mg)
Official label: GastroMycin with Bismuth Salts
Entered into DSLD on 21 November 2019. Withdrawn from the US market on 4 August 2020 (according to the DSLD).- Same quantity, different name: Cinnamon (bark) extract in this version; Cinnamon extract on the displayed label (20 mg)
- Same quantity, different name: Licorice (root) extract in this version; Licorice extract on the displayed label (200 mg)
- Same quantity, different name: Neem (leaf) extract in this version; Neem extract on the displayed label (300 mg)
- Same quantity, different name: Oregon Grape (root) powder in this version; Oregon Grape powder on the displayed label (400 mg)
Official label: GastroMycin with Bismuth Salts
Entered into DSLD on 23 October 2019. Withdrawn from the US market on 4 August 2020 (according to the DSLD).- Same quantity, different name: Cinnamon (bark) extract in this version; Cinnamon extract on the displayed label (20 mg)
- Same quantity, different name: Licorice (root) extract in this version; Licorice extract on the displayed label (200 mg)
- Same quantity, different name: Neem (leaf) extract in this version; Neem extract on the displayed label (300 mg)
- Same quantity, different name: Oregon Grape (root) powder in this version; Oregon Grape powder on the displayed label (400 mg)
Official label: GastroMycin with Bismuth Salts
Entered into DSLD on 7 January 2019. Withdrawn from the US market on 26 June 2019 (according to the DSLD).- Active ingredient added : Goldenseal (root) extract (200 mg)
- Active ingredient added : Licorice (root) extract (200 mg)
- Active ingredient removed : Cinnamon extract (20 mg)
- Active ingredient removed : Licorice extract (200 mg)
- Active ingredient removed : Oregon Grape powder (400 mg)
- Same quantity, different name: Aloe vera concentrate in this version; Aloe vera extract on the displayed label (40 mg)
- Same quantity, different name: Grapefruit (seed) extract in this version; Neem extract on the displayed label (300 mg)
Official label: GastroMycin with Bismuth Salts
Entered into DSLD on 21 September 2017. Withdrawn from the US market on 26 June 2019 (according to the DSLD).- Active ingredient added : Goldenseal (root) extract (200 mg)
- Active ingredient added : Licorice (root) extract (200 mg)
- Active ingredient removed : Cinnamon extract (20 mg)
- Active ingredient removed : Licorice extract (200 mg)
- Active ingredient removed : Oregon Grape powder (400 mg)
- Same quantity, different name: Aloe vera concentrate in this version; Aloe vera extract on the displayed label (40 mg)
- Same quantity, different name: Grapefruit (seed) extract in this version; Neem extract on the displayed label (300 mg)
Official label: GastroMycin with Bismuth Salts
Entered into DSLD on 21 September 2017. Withdrawn from the US market on 19 July 2018 (according to the DSLD).- Active ingredient added : Goldenseal (root) extract (200 mg)
- Active ingredient added : Licorice (root) extract (200 mg)
- Active ingredient removed : Cinnamon extract (20 mg)
- Active ingredient removed : Licorice extract (200 mg)
- Active ingredient removed : Oregon Grape powder (400 mg)
- Same quantity, different name: Aloe vera concentrate in this version; Aloe vera extract on the displayed label (40 mg)
- Same quantity, different name: Grapefruit (seed) extract in this version; Neem extract on the displayed label (300 mg)
Official label: GastroMycin with Bismuth Salts
Entered into DSLD on 25 January 2016. Withdrawn from the US market on 31 July 2017 (according to the DSLD).- Active ingredient added : Goldenseal (root) extract (200 mg)
- Active ingredient added : Licorice (root) extract (200 mg)
- Active ingredient removed : Cinnamon extract (20 mg)
- Active ingredient removed : Licorice extract (200 mg)
- Active ingredient removed : Oregon Grape powder (400 mg)
- Same quantity, different name: Aloe vera concentrate in this version; Aloe vera extract on the displayed label (40 mg)
- Same quantity, different name: Grapefruit (seed) extract in this version; Neem extract on the displayed label (300 mg)
Official label: GastroMycin with Bismuth Salts
Entered into DSLD on 24 May 2013. Withdrawn from the US market on 18 November 2015 (according to the DSLD).- Active ingredient added : Goldenseal (200 mg)
- Active ingredient added : Licorice (root) extract (200 mg)
- Active ingredient removed : Cinnamon extract (20 mg)
- Active ingredient removed : Licorice extract (200 mg)
- Active ingredient removed : Oregon Grape powder (400 mg)
- Same quantity, different name: Aloe Vera concentrate in this version; Aloe vera extract on the displayed label (40 mg)
- Same quantity, different name: Grapefruit (seed) extract in this version; Neem extract on the displayed label (300 mg)
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Aloe vera extract
Read the warning, when it applies and the studies cited
ALOE VERA LEAF GEL - Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Brinker 2010; Mills and Bone 2005; Bartram 1998).
Sources cited by Health Canada (3)
- Bartram T. Bartram's Encyclopedia of Herbal Medicine, 1st edition. London (GB): Robinson Publishing Ltd; 1998.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Applies to products providing 2.4 g or more fresh leaf gel, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Huseini et al. 2012; Pizzorno and Murray 2006).
Sources cited by Health Canada (2)
- Huseini HF, Kianbakht S, Hajiaghaee R, Dabaghian FH. Anti-hyperglycemic and anti-hypercholesterolemic effects of Aloe vera leaf gel in hyperlipidemic type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial. Planta Medica 2012;78(4):311-316. PubMed Randomised trial
- Pizzorno J E, Murray M T. Text Book of Natural Medicine, 3rd edition. St. Louis (MO): Elsevier Churchill Livingstone; 2006.
Condition of application: Demulcent.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 28 March 2025
ALOE - ALOE VERA/ALOE FEROX - Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a kidney disorder or a lazy bowel (EMA 2016; Gardner and McGuffin 2013; Brinker 2010).
Sources cited by Health Canada (3)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2016. European Medicines Agency. Community Herbal Monograph on Aloe Barbadensis Miller and on Aloe (Various Species, Mainly Aloe Ferox Miller And Its Hybrids). London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 22 Novembre 2016. [Accessed 2025 March 14]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-aloe-barbadensis-mill-and-aloe-various-species-mainly-aloe-ferox-mill-and-its-hybrids-folii-succus-siccatus_en.pdf
- Gardner Z, McGuffin M. editors. American Herbal Products Association's Botanical Safety Handbook, 2nd edition. Boca Raton (FL): CRC Press; 2013.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking heart medications, corticosteroids, diuretics, or other health products that may contribute to electrolyte imbalance (EMA 2016; Gardner and McGuffin 2013; Brinker 2010).
Sources cited by Health Canada (3)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2016. European Medicines Agency. Community Herbal Monograph on Aloe Barbadensis Miller and on Aloe (Various Species, Mainly Aloe Ferox Miller And Its Hybrids). London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 22 Novembre 2016. [Accessed 2025 March 14]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-aloe-barbadensis-mill-and-aloe-various-species-mainly-aloe-ferox-mill-and-its-hybrids-folii-succus-siccatus_en.pdf
- Gardner Z, McGuffin M. editors. American Herbal Products Association's Botanical Safety Handbook, 2nd edition. Boca Raton (FL): CRC Press; 2013.
Contraindications
Do not use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Brinker 2010).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Gardner Z, McGuffin M. editors. American Herbal Products Association's Botanical Safety Handbook, 2nd edition. Boca Raton (FL): CRC Press; 2013.
Do not use if you have inflammatory bowel disease, fever or any undiagnosed gastrointestinal trouble (EMA 2016; Gardner and McGuffin 2013; Brinker 2010).
Sources cited by Health Canada (3)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2016. European Medicines Agency. Community Herbal Monograph on Aloe Barbadensis Miller and on Aloe (Various Species, Mainly Aloe Ferox Miller And Its Hybrids). London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 22 Novembre 2016. [Accessed 2025 March 14]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-aloe-barbadensis-mill-and-aloe-various-species-mainly-aloe-ferox-mill-and-its-hybrids-folii-succus-siccatus_en.pdf
- Gardner Z, McGuffin M. editors. American Herbal Products Association's Botanical Safety Handbook, 2nd edition. Boca Raton (FL): CRC Press; 2013.
Known adverse reactions
Stop use if hypersensitivity/allergy or diarrhea occurs (EMA 2016; Brinker 2010).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2016. European Medicines Agency. Community Herbal Monograph on Aloe Barbadensis Miller and on Aloe (Various Species, Mainly Aloe Ferox Miller And Its Hybrids). London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 22 Novembre 2016. [Accessed 2025 March 14]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-aloe-barbadensis-mill-and-aloe-various-species-mainly-aloe-ferox-mill-and-its-hybrids-folii-succus-siccatus_en.pdf
Health Canada monograph dated 28 March 2025
ALOE - ALOE VERA Topical
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Gardner and McGuffin 2013; Brinker 2010).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Gardner Z, McGuffin M. éditeurs. American Herbal Products Association's Botanical Safety Handbook, 2e édition. Boca Raton (FL): CRC Press; 2013.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Allergy Research Group
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “GastroMycin with Bismuth Salts (Allergy Research Group): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/713947710306-gastromycin-with-bismuth-salts-allergy-research-group, updated 18 December 2021.